Kazumi Sano
Kiyose, 2048588, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer.
Journal: BMC cancer
Published: December 31, 2019
Pharmacokinetics of Isoniazid-induced Rhabdomyolysis in a Girl.
Journal: Internal medicine (Tokyo, Japan)
Published: July 10, 2018
Effect of Radiological Countermeasures on Subjective Well-Being and Radiation Anxiety after the 2011 Disaster: The Fukushima Health Management Survey.
Journal: International journal of environmental research and public health
Published: November 17, 2017
Investigation of Bioequivalence Between Brand-name and Generic Irinotecan Products.
Journal: Anticancer research
Published: August 09, 2016
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.
Journal: Cancer chemotherapy and pharmacology
Published: January 24, 2016
Drunkenness caused by isoniazid in a tuberculosis patient with extrapulmonary lesions on hemodialysis: a case report
Journal: Kekkaku : [Tuberculosis]
Published: December 18, 2013
Gefitinib enhances the antitumor activity of CPT-11 in vitro and in vivo by inhibiting ABCG2 but not ABCB1: a new clue to circumvent gastrointestinal toxicity risk.
Journal: Chemotherapy
Published: September 25, 2013
Phase II trial of erlotinib in patients with advanced non‑small‑cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.
Journal: Cancer chemotherapy and pharmacology
Published: April 11, 2013
Evolutionary relations of Hexanchiformes deep-sea sharks elucidated by whole mitochondrial genome sequences.
Journal: BioMed research international
Published: March 01, 2013
The pharmacokinetics and long-term therapeutic effects of gefitinib in patients with lung adenocarcinoma harboring the epidermal growth factor receptor(EGFR)mutation.
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 16, 2012
Last Updated: 09/26/2026